Skip to search formSkip to main contentSkip to account menu

BMY 42393

Known as: BMY-42393 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OxazolesPhenoxyacetates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Prostacyclin receptor‐independent inhibition of phospholipase C activity by non‐prostanoid prostacyclin mimetics
Chinese hamster ovary (CHO) cells were transiently transfected with the mouse prostacyclin (mIP) receptor to examine IP agonist… 
1994
1994
2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
1994
1994
2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis.
1993
1993
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor…
We determined the effects of two prostacyclin agonists (octimibate and BMY 42393) on the progression of the fatty streak in vivo… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)